Pharmafile Logo

Cuttsy+Cuttsy awarded Gold EcoVadis sustainability rating

December 11, 2024 | ESG, Sustainability 

Cuttsy+Cuttsy proudly announces their Gold Medal achievement from EcoVadis for 2024, placing them among the top 5% of companies assessed and within the 97th percentile, a testament to their unwavering commitment to sustainability and advanced ESG practices.

EcoVadis Gold Medal

Following the assessment of the 2024 EcoVadis submission, Cuttsy+Cuttsy is excited to announce they have been awarded a Gold Medal on their sustainability scorecard. This places the agency among the top 5% of companies assessed by EcoVadis in the past 12 months.

Not only this, but Cuttsy+Cuttsy’s high score placed them in the 97th percentile of all companies assessed in 2024, making them just shy of a platinum rating (the top possible rating within the EcoVadis scoring system).

EcoVadis, a globally trusted provider of business sustainability ratings with a network of over 130,000 rated companies, works with organisations of all sizes to measure sustainability performance. The platform offers detailed insights on environmental, social and governance (ESG) risk management, compliance and corporate sustainability goals.

Caroline Benson, Co-Founder, says, “We’re delighted with our ‘gold’ rating, a big advancement from last year’s ‘silver’, that showcases our dedication to continuous improvement across all our ESG practices.”

Mathew Cutts adds, “This achievement reinforces our pledge to uphold and exceed the highest standards in sustainability across our operations and value chain.”

This content was provided by Cuttsy + Cuttsy

Company Details

 Latest Content from  Cuttsy + Cuttsy 

Cuttsy+Cuttsy achieves Platinum accreditation from Investors in People

Cuttsy+Cuttsy is proud to have achieved a Platinum accreditation from Investors in People, placing them among the top 2% of organisations assessed globally.

Cuttsy+Cuttsy awarded Gold EcoVadis sustainability rating

Cuttsy+Cuttsy proudly announces their Gold Medal achievement from EcoVadis for 2024, placing them among the top 5% of companies assessed and within the 97th percentile, a testament to their unwavering...

Age is not just a number when it comes to clinical trials

In this blog we look at the critical underrepresentation of older adults in clinical trials, emphasising the need for inclusive trial designs and targeted strategies to ensure safe and effective...

How to boost clinical trial access and make patients health-empowered

Clinical research is becoming more patient-centric, but there's still more that needs to be done to make clinical trials available to everyone. This could include wider participation.

Closing the loop: Why clinical trial results matter to participants

Discover why sharing clinical trial results with participants is crucial for respect, informed health decisions, and fostering strong researcher-participant partnerships.

Unveiling the truth: A journey into women’s representation in clinical trials

We explore the historical exclusion of women from clinical trials, its consequences on medical research and treatment efficacy and the ongoing efforts to ensure their representation.

Clarity in clinical trials

Discover how transparent, empathetic communication and health literacy principles can empower patients and enhance engagement in clinical trials, transforming participants into active partners in their healthcare journey.

Caring for patients’ mental health in clinical trials

We look at why ensuring continuous mental health support for patients in clinical trials is essential to enhance their overall well-being and trial engagement.

Driving equitable healthcare: The role of DE&I in clinical trials

Diversity, equity and inclusion (DE&I) is becoming a bigger topic of conversation and meaningful action within clinical trials. And for good reason, too. Find out why we embrace this and...

Empowering patients through more accessible clinical trial information

Senior Medical Writer, Scott Palmer explores the challenges and solutions in enhancing patient engagement in clinical trials, from the pivotal role of healthcare professionals, to the importance of user-friendly trial...